22 May 2013
Keywords: solvay, licenses, omacor, pronova, biocare, belgium, pharmaceuticals
Article | 12 December 2001
Belgium's Solvay Pharmaceuticals has expanded its cardiovascular drugfranchise with the licensing of Omacor (concentrated omega-3 polyunsaturated fatty acids), a product ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.